Using the chemical KDM4 protein inhibitor QC6352 as well as KDM4A silencing by epi-editing, we corroborated the ability of inhibiting KDM4 to reduce cancer cell viability [31, 32, 73] for breast and colorectal cancers [12, 74]. This evidence concerns the gene KDM4A and colorectal cancer.